The following reports were submitted by Erin Rowley – 2016 Advocate
- Triple -Negative Trial: Carboplatin vs. Docetaxel in Women with Metastatic Tumors That Have “Silenced ” BRCA1 Gene
- Study of the Benefit of Adding Bisphosphonate to Treatment for Early-Stage Hormone Receptor-Positive Breast Cancer. Erin Rowley 2016 Advocate